Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Lantern Pharma Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +1 vs. Q1 2022
- Shares held
- 1.42M
- −34.5K (−2.4%) vs. Q1 2022
- Total value
- $8.06M
- −$2.32M (−22.4%) vs. Q1 2022
- New holders
- 2
- 10 more added
- Sold out
- 1
- 10 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LTRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $12.0M |
| Q1 2026 | 33 | $2.87M |
| Q4 2025 | 33 | $6.91M |
| Q3 2025 | 30 | $9.89M |
| Q2 2025 | 35 | $7.11M |
| Q1 2025 | 32 | $8.62M |
| Q4 2024 | 32 | $8.00M |
| Q3 2024 | 31 | $4.90M |
| Q2 2024 | 39 | $6.01M |
| Q1 2024 | 34 | $9.75M |
| Q4 2023 | 30 | $4.94M |
| Q3 2023 | 27 | $3.93M |
| Q2 2023 | 25 | $6.50M |
| Q1 2023 | 21 | $5.23M |
| Q4 2022 | 23 | $5.40M |
| Q3 2022 | 26 | $6.84M |
| Q2 2022 | 26 | $8.06M |
| Q1 2022 | 25 | $10.4M |
| Q4 2021 | 33 | $13.1M |
| Q3 2021 | 25 | $15.7M |
| Q2 2021 | 22 | $19.7M |
| Q1 2021 | 24 | $25.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Lantern Pharma Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 132 | $1.00K | 0.00% | −1,158−89.8% | Reduced |
| GHP Investment Advisors, Inc. | 300 | $2.00K | 0.00% | +300 | New |
| Steward Partners Investment Advisory, LLC | 450 | $3.00K | 0.00% | +150+50.0% | Added |
| Simplex Trading, LLC | 1,037 | $5.00K | 0.00% | +228+28.2% | Added |
| Tower Research Capital LLC (TRC) | 1,127 | $6.00K | 0.00% | +354+45.8% | Added |
| Morgan Stanley | 1,394 | $8.00K | 0.00% | −11,507−89.2% | Reduced |
| Spire Wealth Management | 2,025 | $12.0K | 0.00% | −2,025−50.0% | Reduced |
| Urban Wealth Management, LLC | 2,472 | $14.0K | 0.05% | +2,472 | New |
| Advisor Group Holdings, Inc. | 3,360 | $19.0K | 0.00% | +285+9.3% | Added |
| JPMorgan Chase & Co | 3,746 | $21.0K | 0.00% | −4,272−53.3% | Reduced |
| Wells Fargo & Company | 3,780 | $21.0K | 0.00% | +222+6.2% | Added |
| UBS Group AG | 12,050 | $69.0K | 0.00% | −1,886−13.5% | Reduced |
| Northern Trust Corp | 12,629 | $72.0K | 0.00% | 00.0% | Unchanged |
| Sigma Planning Corp | 17,600 | $100.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 22,100 | $126.0K | 0.00% | +11,400+106.5% | Added |
| BlackRock Inc. | 22,762 | $129.0K | 0.00% | −312−1.4% | Reduced |
| Bank of New York Mellon Corp | 26,480 | $151.0K | 0.00% | −285−1.1% | Reduced |
| State Street Corp | 27,752 | $158.0K | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 31,575 | $180.0K | 0.13% | −4,580−12.7% | Reduced |
| CM Management, LLC | 45,100 | $258.0K | 0.27% | +11,335+33.6% | Added |
| Redmond Asset Management, LLC | 49,664 | $284.0K | 0.10% | −129−0.3% | Reduced |
| Geode Capital Management, LLC | 57,564 | $328.0K | 0.00% | +521+0.9% | Added |
| GWM Advisors LLC | 169,972 | $971.0K | 0.02% | +201+0.1% | Added |
| Carlson Capital L P | 170,000 | $971.0K | 0.07% | +2,700+1.6% | Added |
| Sanders Morris Harris LLC | 366,030 | $2.06M | 0.45% | −18,198−4.7% | Reduced |
| Vanguard Group Inc | 367,319 | $2.10M | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −20,322−100.0% | Sold out |